CAFERRA, PAOLO Statistiche
CAFERRA, PAOLO
DIPARTIMENTO DI FARMACIA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.001 secondi).
Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective
2024-01-01 Caferra, Paolo; Fraisse, Thomas; Trincavelli, Maria Letizia; Marchetti, Laura; Piras, Anna Maria
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
2024-01-01 Brose, M. S.; Capdevila, J.; Elisei, R.; Bastholt, L.; Fuhrer-Sakel, D.; Leboulleux, S.; Sugitani, I.; Taylor, M. H.; Wang, Z.; Wirth, L. J.; Worden, F. P.; Bernard, J.; Caferra, P.; Colzani, R. M.; Liu, S.; Schlumberger, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective | 1-gen-2024 | Caferra, Paolo; Fraisse, Thomas; Trincavelli, Maria Letizia; Marchetti, Laura; Piras, Anna Maria | |
| Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy | 1-gen-2024 | Brose, M. S.; Capdevila, J.; Elisei, R.; Bastholt, L.; Fuhrer-Sakel, D.; Leboulleux, S.; Sugitani, I.; Taylor, M. H.; Wang, Z.; Wirth, L. J.; Worden, F. P.; Bernard, J.; Caferra, P.; Colzani, R. M.; Liu, S.; Schlumberger, M. |